Secondary glioblastoma multiforme in a pediatric patient. Case presentation and review of the literature
Keywords:
Glioblastoma Multiforme, Neurofibromatosis 2, NeurosurgeryAbstract
Introduction: Glioblastoma Multiforme is a primary neoplasm of the Central Nervous System. They are aggressive tumors classified according to the World Health Organization as grade IV gliomas, with peak incidence by age between 40 and 70 years old, being infrequent in pediatric ages. The prognosis of this entity is unfavorable at any age and life expectancy does not exceed 6 months after diagnosis.
Case presentation: 9-year-old female school patient with a history of Neurofibromatosis type 2, with initial diagnosis of Pleomorphic Xanthoastrocytoma that progressed to Secondary Glioblastoma Multiforme. The patient underwent surgery and received the corresponding oncologic treatment.
Conclusions: GBM is an aggressive neoplasm with a poor prognosis for life at any age. The presented case is an achievement for Pediatric Neurosurgery in the country, because after 19 months of surgical intervention and oncologic treatment the patient shows a clinical and imageneological improvement.
Downloads
References
1. Pollack IF, Agnihotri S, Broniscer A. Childhood brain tumors: current management, biological insights, and future directions. J Neurosurg Pediatr [Internet]. 2019 [citado 03 May 2022];23(3):261-73. Disponible en: https://thejns.org/downloadpdf/journals/j-neurosurg-pediatr/23/3/article-p261.pdf
2. Kanderi T, Gupta V. Glioblastoma Multiforme [Internet]. USA: StatPearls Publishing LLC; 2021 [citado 03 May 2022] Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK558954/
3. Huttner A. Overview of primary brain tumors: pathologic classification, epidemiology, molecular biology, and prognostic markers. Hematol Oncol Clin North Am [Internet]. 2012 [citado 03 May 2022];26(4):715-32. Disponible en: https://www.sciencedirect.com/science/article/abs/pii/S0889858812000780?via%3Dihub
4. Muñoz Hidalgo L, San Miguel T, Megías J, Monleón D, Navarro L, Roldán P, et al. Somatic copy number alterations are associated with EGFR amplification and shortened survival in patients with primary glioblastoma. Neoplasia [Internet]. 2020 [citado 03 May 2022];22(1):10-21. Disponible en: https://reader.elsevier.com/reader/sd/pii/S1476558619302428?token=29845A853EF754633E3F511804E99B65581DBE4B29BCD5E8FF42D3D6F521D57E8716725F8A29D04A21C8C345D42DB9AD&originRegion=eu-west-1&originCreation=20220503141335
5. Cuba. Ministerio de Salud Pública (MINSAP). Anuario Estadístico de Salud 2019 [Internet]. La Habana: MINSAP. Dirección Nacional de Estadísticas de Salud; 2020 [citado 03 May 2022]. Disponible en: https://files.sld.cu/bvscuba/files/2020/05/Anuario-Electr%C3%B3nico-Espa%C3%B1ol-2019-ed-2020.pdf
6. Colao A, Pirchio R. Pituitary Tumors in Childhood [Internet]. USA: MDText.com, Inc; 2021 [citado 03 May 2022] Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK279057/
7. Castañeda CA, Casavilca S, Orrego E, García Corrochano P, Deza P, Heinike H, et al. Glioblastoma: análisis molecular y sus implicancias clínicas. Rev Peru Med Exp Salud Pública [Internet]. 2015 [citado 03 May 2022];32(2):316-25. Disponible en: https://www.redalyc.org/articulo.oa?id=36341083017
8. Kuttech JF, Zieber Rush S, Ater JL: Tumores Cerebrales en la infancia. En: Kliegman RM, Geme JS, Blum N, Shah SS, Tasker BC. Nelson Tratado de Pediatría. 21a ed. España: El Sevier; 2020.
9. Sierra Benítez EM, León Pérez MQ, Morales Fuentes MA. Avances neuroquirúrgicos y biología molecular en el tratamiento del glioblastoma multiforme. Rev Med Electrón [Internet]. 2019 [citado 03 May 2022];41(5):1230-41. Disponible en: http://scielo.sld.cu/pdf/rme/v41n5/1684-1824-rme-41-05-1230.pdf
10. Johnson KJ, Cullen J, Barnholtz Sloan JS, Ostrom QT, Langer CE, Turner MC, et al. Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review. Cancer Epidemiol Biomarkers Prev [Internet]. 2014 [citado 03 May 2022];23(12):2716-36. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4257885/pdf/nihms626160.pdf
11. Tejada Solísa S, Plans Ahicartb G, Iglesias Lozanoc I, Quintana Schmidtd C de, Fernández Coello A, Hostalot Panisello C, et al. Consenso sobre guías de tratamiento de los glioblastomas elaborado por el Grupo de Trabajo de Neurooncología (GTNO) de la SENEC. Neurocirugía [Internet]. 2020; [citado 03 May 2022];31(6):289–98. Disponible en: https://www.sciencedirect.com/science/article/pii/S1130147320300828?via%3Dihub
12. Mihelson N, McGavern DB. Viral Control of Glioblastoma. Viruses [Internet]. 2021 [citado 03 May 2022];13(7):1264-77. Disponible en: https://mdpi-res.com/d_attachment/viruses/viruses-13-01264/article_deploy/viruses-13-01264-v2.pdf?version=1625041856
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: authors retain their copyright and grant the journal the right of first publication of their work, which is simultaneously subject to the Creative Commons Attribution-NonCommercial 4.0 International License that allows third parties to share the work as long as the author and first publication in this journal are indicated, for non-commercial use. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional telematic archive or publishing it in a monographic volume) as long as the initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work via the Internet (e.g., in institutional telematic archives, in their web page or in Pre-print servers) before and during the submission process, which can lead to interesting exchanges and increase citations of the published work. (See The Open Access Effect).
